Medigen Vaccine Biologics Corporation (6547.TWO)
TWD 41.0
(-5.86%)
TWD 41.0
(-5.86%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 6.09 Billion TWD | -17.08% |
| 2022 | 7.34 Billion TWD | 38.66% |
| 2021 | 5.29 Billion TWD | 51.8% |
| 2020 | 3.49 Billion TWD | 53.3% |
| 2019 | 2.27 Billion TWD | 4.3% |
| 2018 | 2.18 Billion TWD | 2.18% |
| 2017 | 2.13 Billion TWD | 17.56% |
| 2016 | 1.81 Billion TWD | 9.91% |
| 2015 | 1.65 Billion TWD | 36.13% |
| 2014 | 1.21 Billion TWD | 154.43% |
| 2013 | 477.4 Million TWD | 217.95% |
| 2012 | 150.15 Million TWD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q2 | 4.3 Billion TWD | -27.44% |
| 2024 Q1 | 5.93 Billion TWD | -2.58% |
| 2023 Q1 | 6.98 Billion TWD | -4.99% |
| 2023 Q3 | 6.62 Billion TWD | -0.47% |
| 2023 Q2 | 6.65 Billion TWD | -4.7% |
| 2023 Q4 | 6.09 Billion TWD | -7.99% |
| 2023 FY | 6.09 Billion TWD | -17.08% |
| 2022 Q4 | 7.34 Billion TWD | -7.83% |
| 2022 Q3 | 7.97 Billion TWD | -3.44% |
| 2022 Q2 | 8.25 Billion TWD | 57.92% |
| 2022 FY | 7.34 Billion TWD | 38.66% |
| 2022 Q1 | 5.22 Billion TWD | -1.35% |
| 2021 Q2 | 4.11 Billion TWD | 18.67% |
| 2021 FY | 5.29 Billion TWD | 51.8% |
| 2021 Q4 | 5.29 Billion TWD | 18.92% |
| 2021 Q1 | 3.46 Billion TWD | -0.61% |
| 2021 Q3 | 4.45 Billion TWD | 8.23% |
| 2020 Q4 | 3.49 Billion TWD | 57.08% |
| 2020 FY | 3.49 Billion TWD | 53.3% |
| 2020 Q1 | 2.5 Billion TWD | 10.04% |
| 2020 Q2 | 2.33 Billion TWD | -6.91% |
| 2020 Q3 | 2.22 Billion TWD | -4.72% |
| 2019 FY | 2.27 Billion TWD | 4.3% |
| 2019 Q2 | 2.19 Billion TWD | -6.67% |
| 2019 Q3 | 2.06 Billion TWD | -5.59% |
| 2019 Q4 | 2.27 Billion TWD | 10.05% |
| 2019 Q1 | 2.34 Billion TWD | 7.56% |
| 2018 Q4 | 2.18 Billion TWD | -6.01% |
| 2018 FY | 2.18 Billion TWD | 2.18% |
| 2018 Q3 | 2.32 Billion TWD | -4.53% |
| 2018 Q2 | 2.43 Billion TWD | 20.39% |
| 2018 Q1 | 2.02 Billion TWD | -5.42% |
| 2017 Q3 | 2.12 Billion TWD | 15.33% |
| 2017 Q2 | 1.84 Billion TWD | 0.0% |
| 2017 Q1 | - TWD | -100.0% |
| 2017 FY | 2.13 Billion TWD | 17.56% |
| 2017 Q4 | 2.13 Billion TWD | 0.62% |
| 2016 Q1 | 1.65 Billion TWD | 0.31% |
| 2016 Q2 | 1.65 Billion TWD | 0.0% |
| 2016 Q4 | 1.81 Billion TWD | 0.0% |
| 2016 FY | 1.81 Billion TWD | 9.91% |
| 2015 Q3 | 1.65 Billion TWD | 43.86% |
| 2015 Q1 | 1.14 Billion TWD | -5.37% |
| 2015 Q2 | 1.14 Billion TWD | 0.0% |
| 2015 FY | 1.65 Billion TWD | 36.13% |
| 2015 Q4 | 1.65 Billion TWD | 0.0% |
| 2014 FY | 1.21 Billion TWD | 154.43% |
| 2014 Q1 | - TWD | 0.0% |
| 2014 Q3 | 1.21 Billion TWD | 0.0% |
| 2014 Q4 | 1.21 Billion TWD | 0.0% |
| 2013 FY | 477.4 Million TWD | 217.95% |
| 2012 FY | 150.15 Million TWD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| SYN-TECH Chem. & Pharm. Co., Ltd. | 2.9 Billion TWD | -110.027% |
| Level Biotechnology Inc. | 822.67 Million TWD | -640.591% |
| Sagittarius Life Science Corp | 664.72 Million TWD | -816.569% |
| NeoCore Technology Co., Ltd. | 548.74 Million TWD | -1010.281% |
| TaiMed Biologics Inc. | 3.89 Billion TWD | -56.466% |
| GlycoNex Incorporation | 1.55 Billion TWD | -292.362% |
| VBI | 452.1 Million TWD | -1247.626% |
| GeneReach Biotechnology Corp. | 1.17 Billion TWD | -418.02% |
| Taiwan Advance Bio-Pharmaceutical Inc. | 748.57 Million TWD | -713.904% |
| Visgeneer Inc. | 397.17 Million TWD | -1433.991% |
| Mycenax Biotech Inc. | 3.77 Billion TWD | -61.591% |
| Sunmax Biotechnology Co., Ltd. | 2.15 Billion TWD | -182.193% |
| G&E Herbal Biotechnology Co., Ltd. | 883.09 Million TWD | -589.92% |
| TaiwanJ Pharmaceuticals Co., Ltd. | 73.55 Million TWD | -8182.778% |
| Enimmune corporation | 604.82 Million TWD | -907.337% |
| TaiRx, Inc. | 833.74 Million TWD | -630.756% |
| CHO Pharma, Inc. | 3.08 Billion TWD | -97.427% |
| EirGenix Inc. | 11.16 Billion TWD | 45.419% |
| BioLASCO Taiwan Co., Ltd. | 573.13 Million TWD | -963.031% |
| Sunny Pharmtech Inc. | 1.71 Billion TWD | -255.803% |
| Lin BioScience, Inc. | 3.59 Billion TWD | -69.394% |
| BioGend Therapeutics Co., Ltd. | 1.05 Billion TWD | -479.986% |
| Feng Chi Biotech Corp. | 301.03 Million TWD | -1923.92% |
| Bio Preventive Medicine Corp. | 264.65 Million TWD | -2202.091% |
| Lukas Biomedical Inc. | 441.19 Million TWD | -1280.954% |
| RBC Bioscience Corporation | 753.79 Million TWD | -708.268% |
| BiOptic Inc. | 613.77 Million TWD | -892.655% |
| BRIM Biotechnology, Inc. | 1.77 Billion TWD | -242.539% |
| Shine-On BioMedical Co.,Ltd. | 1.15 Billion TWD | -425.357% |
| Great Novel Therapeutics Biotech & Medicals | 644.84 Million TWD | -844.817% |
| Syngen Biotech Co.,Ltd. | 3.1 Billion TWD | -96.141% |
| Anti-Microbial Savior BioteQ Co., Ltd | 128.04 Million TWD | -4658.133% |
| SynCore Biotechnology Co.,Ltd | 378.36 Million TWD | -1510.269% |
| Genomics BioSci & Tech. Co.,Ltd. | 1.13 Billion TWD | -437.344% |
| Neith Corporation | 192.15 Million TWD | -3070.726% |
| Advagene Biopharma Co., Ltd. | 147.93 Million TWD | -4018.489% |
| NaviFUS Corp. | 490.53 Million TWD | -1142.041% |
| Gwo Xi Stem Cell Applied Technology Co. , Ltd | 1.22 Billion TWD | -397.068% |
| Sinew Pharma Inc. | 1.36 Billion TWD | -346.88% |
| Andros Pharmaceuticals Co.,Ltd | 529.14 Million TWD | -1051.411% |
| Greenyn Biotechnology Co., Ltd | 1.16 Billion TWD | -424.601% |
| Lumosa Therapeutics Co., Ltd. | 1.65 Billion TWD | -267.851% |
| AP Biosciences Inc | 890.75 Million TWD | -583.986% |
| Medigen Biotechnology Corp. | 8.52 Billion TWD | 28.551% |
| 3D Global Biotech Inc. | 324.14 Million TWD | -1779.588% |
| Pharmosa Biopharm Inc. | 1.33 Billion TWD | -356.842% |
| Intech Biopharm Corporation | 2.71 Billion TWD | -124.732% |
| Oneness Biotech Co., Ltd. | 15.36 Billion TWD | 60.344% |
| Eusol Biotech Co.,Ltd. | 410.25 Million TWD | -1385.077% |
| TWi Biotechnology, Inc. | 396.85 Million TWD | -1435.248% |
| Ever Supreme Bio Technology Co., Ltd | 2.07 Billion TWD | -193.491% |
| TCI GENE Inc. | 1.16 Billion TWD | -422.552% |
| MegaPro Biomedical Co., Ltd | 294.58 Million TWD | -1968.241% |
| Senhwa Biosciences, Inc. | 1.36 Billion TWD | -346.894% |
| Taiwan Bio Therapeutics Co., Ltd | 941.76 Million TWD | -546.942% |
| NatureWise Biotech & Medicals Corporation | 698.45 Million TWD | -772.308% |
| PharmaEngine, Inc. | 3.95 Billion TWD | -54.091% |
| Savior Lifetec Corporation | 3.82 Billion TWD | -59.382% |
| TaiGen Biopharmaceuticals Holdings Limited | 1.22 Billion TWD | -395.402% |
| OBI Pharma, Inc. | 5.6 Billion TWD | -8.722% |
| Meribank Biotech Co., Ltd | 1.06 Billion TWD | -473.691% |
| Acepodia, Inc. | 6.81 Billion TWD | 10.646% |
| Caliway Biopharmaceuticals Co., Ltd. | 3.82 Billion TWD | -59.222% |